Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03785184
Title A Study of Venetoclax Plus Lenalidomide and Dexamethasone for the Treatment of Newly Diagnosed t(11;14)-Positive Multiple Myeloma in Subjects Who Are Ineligible for High-Dose Therapy
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors AbbVie
Age Groups: adult | senior
Covered Countries USA | ESP | CAN

No variant requirements are available.